A Boston Scientist Says We've Been Fighting Cancer Wrong For 100 Years. Ghana's Changing Diet Makes This Argument Impossible To Ignore

For nearly a century, the world's cancer research establishment has operated on one foundational belief: cancer is, at its core, a disease of broken genes — cells that mutate, escape their normal controls, and multiply without limit. Billions of dollars, entire scientific careers, and the whole architecture of modern oncology rest on that premise.

Dr. Thomas Seyfried, a Boston College professor with over 150 peer-reviewed publications to his name, is not a fringe internet commentator. He is a credentialed research scientist, and he has spent decades building the case that this foundational premise is, at minimum, dangerously incomplete. His argument, distilled from his own research and laid out most fully in his book Cancer as a Metabolic Disease, is that cancer behaves less like a genetic accident and more like a breakdown in how cells produce energy — specifically, a shift toward fermentation-based metabolism even when oxygen is available, a phenomenon first observed nearly a century ago and known to science as the Warburg effect.

Whether or not you accept his full conclusion, the argument he is making deserves a serious hearing in Ghana, for reasons that have nothing to do with Boston and everything to do with what is now on our own plates.

I must be direct about something before I go further

This column engages seriously with a genuine scientific debate. It is not medical advice, and nothing in it should be read as a suggestion that diet can replace surgery, chemotherapy, radiation, or any treatment prescribed by a qualified oncologist. If you or someone you love has cancer, the only responsible first call is to a doctor, not a column. With that said plainly, let us look honestly at what is actually being debated.

The nut of the matter
Here is the argument, stated as fairly as I can put it: Seyfried and a minority of researchers argue that cancer cells' near-universal reliance on fermentation for energy, even in the presence of oxygen, points to a damaged cellular energy system — the mitochondria — as the disease's true origin, with genetic mutations following as a downstream consequence rather than the root cause. Mainstream oncology largely disagrees, maintaining that genetic mutation remains the primary driver, with metabolic changes occurring as an important contributing factor rather than the fundamental cause. This is a real, unresolved scientific dispute, not a case of one side possessing obvious truth and the other willful ignorance. But regardless of which camp turns out to be more correct, the lifestyle and dietary factors sitting underneath this entire debate are worth Ghana's urgent attention.

Steel-manning the mainstream position, honestly

It would be intellectually dishonest to present Seyfried's view without also crediting the case against it, because it is a substantial case. Decades of genomic research have identified specific, reproducible mutations driving specific cancers, and treatments targeting those exact mutations — certain breast cancer therapies, some leukemia treatments, targeted therapies for particular lung cancers — have measurably extended lives and, in some cases, achieved remission where none previously existed. Critics of the purely metabolic framing argue, reasonably, that reducing an extraordinarily diverse family of over 200 distinct diseases to a single metabolic mechanism oversimplifies decades of genetic evidence, and that abandoning genetically targeted treatment in favour of metabolic therapy alone would cost lives rather than save them. That caution is not obstruction. It is appropriate scientific rigor protecting patients from unproven substitutes for treatments that demonstrably work.

What is not actually in dispute
Step back from the theoretical argument for a moment, because underneath it sits a set of facts about diet, metabolism, and cancer risk that both mainstream oncology and Seyfried's camp broadly accept. Obesity is a well-established risk factor for multiple cancers, including colorectal, breast, and liver cancer. Chronic high blood sugar and insulin resistance are linked to increased cancer risk through multiple confirmed biological pathways. Excessive consumption of ultra-processed food and sugar is associated with higher rates of the metabolic dysfunction — diabetes, obesity, fatty liver disease — that sits upstream of significant cancer risk. None of this requires you to take a side in the genetic-versus-metabolic debate. It requires only that you accept what mainstream medical bodies worldwide, including the World Health Organization, already state plainly.

Why this argument lands differently in Ghana than in Boston

Here is where this stops being an academic dispute for a Western audience and becomes urgent Ghanaian news. Our diet has changed dramatically within a single generation. Traditional Ghanaian eating patterns — heavy in vegetables, legumes, whole grains, and modest portions of starch — are steadily giving way in our cities to imported processed foods, sugary drinks, and fried fast food, particularly among younger, urban Ghanaians who increasingly see traditional cooking as slow and old-fashioned. At the same time, Ghana, like much of Africa, is recording rising rates of the non-communicable diseases — diabetes, obesity, certain cancers — that were once considered primarily Western health problems.

This is not a coincidence colliding with Seyfried's research by accident. It is exactly the collision his research predicts.

The keto question, handled with real caution

Seyfried's proposed intervention — ketogenic metabolic therapy, sometimes combined with other approaches, aimed at starving cancer cells of the fermentable fuel they rely on — remains, by his own account and by the broader scientific record, an area of ongoing, preliminary research rather than an established standard of cancer care anywhere in the world, including the United States. Some small studies and individual case reports are genuinely promising. None currently amount to the kind of large-scale, rigorously controlled clinical evidence that would justify replacing conventional oncology with dietary therapy alone. Readers should hold that distinction clearly: promising research direction, not proven cancer treatment.

What Ghana should actually take from this debate

This is not a call for Ghanaians to fear their doctors or distrust conventional cancer treatment, which remains the only evidence-based path for anyone currently facing this disease. It is a call for Ghana to take far more seriously the preventive side of this argument, on which there is genuine scientific consensus rather than dispute. Our public health messaging on sugar consumption, particularly in beverages aggressively marketed to Ghanaian children and young adults, deserves the same seriousness we have historically given to malaria and cholera prevention. Our urban food environment, increasingly dominated by imported processed products, deserves policy attention rather than passive acceptance as the inevitable cost of modernization. And our medical schools and public health institutions should be engaging seriously with metabolic health research, including contested arguments like Seyfried's, rather than either uncritically adopting them or dismissing them without genuine scrutiny.

A country that waits until its cancer wards resemble those of the countries it is currently imitating dietarily will have learned this lesson far too late and at far too high a cost.

The circle closes
Return to that foundational premise a century of oncology has been built upon — cancer as a disease written in broken genes. Dr. Seyfried has not proven that premise wrong. What he has done, credibly and rigorously enough to demand a hearing, is force a serious re-examination of how much of the disease's origin sits not in our genes alone, but in the daily, cumulative chemistry of what we eat, how our bodies process it, and how far Ghana's own diet has already drifted from the one that once protected us.

We do not need to resolve a century-old scientific argument to act on the parts of it nobody seriously disputes.

The plate in front of you tonight is not just dinner. Increasingly, the evidence suggests, it is medicine or its opposite — and Ghana has not yet decided, as a country, which one it is choosing to serve.

About the author
Chief Tutu Baffour Asare Brownsy Williams is a Ghanaian columnist and commentator writing on public health, food systems, and science through a distinctly West African lens for Modern Ghana, with a readership spanning Accra, Kumasi, and the Ghanaian diaspora across the UK, USA, Canada, and Germany. His writing regularly examines the health consequences of Ghana's rapidly changing diet and urban food environment, and the public policy response he believes it demands.

Author's note: The scientific debate over cancer's genetic versus metabolic origins is real, ongoing, and worth Ghana's attention — but it is not the same as medical advice for an individual patient. If you or someone you love is living with cancer, please consult a qualified oncologist before making any decision about treatment or diet. This column engages with a research debate; it does not replace the judgment of a doctor who knows your specific case.